Company logo

HUM - Humana Inc.

NYSE -> Healthcare -> Healthcare Plans
Louisville, United States
Type: Equity

HUM price evolution
HUM
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $4694 $15148 $16214 $13735
Short term investments $16626 $15145 $15251 $14932
Net receivables $2035 $1824 $1429 $3107
Inventory
Total current assets $29986 $38253 $38759 $37532
Long term investments $1122 $1132 $1122 $1110
Property, plant & equipment $3030 $3342 $3309 $3234
Goodwill & intangible assets $9550 $9540 $9539 $9320
Total noncurrent assets $17079 $17652 $17696 $17244
Total investments $17748 $16277 $16373 $16042
Total assets $47065 $55905 $56455 $54776
Current liabilities
Accounts payable $6569 $17796 $18422 $17449
Deferred revenue $266 $7536 $7378 $7220
Short long term debt $1796 $2491 $2479 $2273
Total current liabilities $8278 $27823 $28279 $26942
Long term debt $10213 $9483 $9722 $9743
Total noncurrent liabilities $11875 $11078 $11285 $11200
Total debt $12009 $11974 $12201 $12016
Total liabilities $30803 $38901 $39564 $38142
Shareholders' equity
Retained earnings $27540 $28191 $27468 $26619
Other shareholder equity -$999 -$1503 -$1226 -$1113
Total shareholder equity $16262 $16949 $16834 $16577
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $4694 $5061 $3394 $4673
Short term investments $16626 $13881 $13192 $12554
Net receivables $2035 $1674 $1814 $1138
Inventory
Total current assets $29986 $26183 $24893 $23641
Long term investments $1122 $1129 $921 $2382
Property, plant & equipment $3030 $3221 $3073 $2371
Goodwill & intangible assets $9550 $9142 $11092 $4447
Total noncurrent assets $17079 $16872 $19465 $11328
Total investments $17748 $15010 $14113 $14936
Total assets $47065 $43055 $44358 $34969
Current liabilities
Accounts payable $6569 $5238 $12798 $12156
Deferred revenue $266 $286 $254 $318
Short long term debt $1796 $2390 $2279 $920
Total current liabilities $8278 $7914 $15331 $13394
Long term debt $10213 $9034 $10541 $6060
Total noncurrent liabilities $11875 $10507 $12924 $7847
Total debt $12009 $11424 $12820 $6980
Total liabilities $30803 $27744 $28255 $21241
Shareholders' equity
Retained earnings $27540 $25492 $23086 $20517
Other shareholder equity -$999 -$1304 $42 $391
Total shareholder equity $16262 $15311 $16080 $13728
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $26423 $26747 $26742
Cost of revenue $21745 $22009 $21858
Gross Profit $4678 $4738 $4884
Operating activities
Research & development
Selling, general & administrative $3271 $3111 $2979
Total operating expenses $3472 $3302 $3165
Operating income $1206 $1436 $1719
Income from continuing operations
EBIT $1202 $1375 $1711
Income tax expense $256 $296 $359
Interest expense $114 $120 $113
Net income
Net income $832 $959 $1239
Income (for common shares) $832 $959 $1239
(in millions $) 31 Jan 2024 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $106374 $92870 $77155
Cost of revenue $75690 $61628
Gross Profit $17180 $15527
Operating activities
Research & development
Selling, general & administrative $12671 $10052
Total operating expenses $102361 $13380 $10541
Operating income $3800 $4986
Income from continuing operations
EBIT $3969 $4957
Income tax expense $836 $762 $1307
Interest expense -$493 $401 $283
Net income
Net income $2489 $2806 $3367
Income (for common shares) $2806 $3367
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $832 $959 $1239
Operating activities
Depreciation $235 $226 $218
Business acquisitions & disposals -$34 -$116 -$73
Stock-based compensation $53 $51 $38
Total cash flows from operations $1252 $3176 $6687
Investing activities
Capital expenditures -$234 -$264 -$223
Investments -$317 -$353 -$996
Total cash flows from investing -$3492 -$585 -$733 -$1292
Financing activities
Dividends paid -$431 -$109 -$111 -$100
Sale and purchase of stock -$379 -$529 -$94
Net borrowings -$201 $177 $582
Total cash flows from financing -$856 -$1733 $36 $3279
Effect of exchange rate
Change in cash and equivalents -$367 -$1066 $2479 $8674
(in millions $) 31 Jan 2024 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $2806 $2933 $3367
Operating activities
Depreciation $845 $713 $616
Business acquisitions & disposals $2364 -$4187 -$709
Stock-based compensation $216 $180 $181
Total cash flows from operations $4587 $2262 $5639
Investing activities
Capital expenditures -$1120 -$1316 -$964
Investments -$2250 -$1053 -$1392
Total cash flows from investing -$3492 -$1006 -$6556 -$3065
Financing activities
Dividends paid -$431 -$392 -$354 -$323
Sale and purchase of stock -$2096 -$58 -$1771
Net borrowings -$1428 $3733 $1078
Total cash flows from financing -$856 -$1914 $3015 -$1955
Effect of exchange rate
Change in cash and equivalents -$367 $1667 -$1279 $619
Fundamentals
Market cap $42.72B
Enterprise value $50.03B
Shares outstanding 122.22M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 2.47
Book/Share 141.22
Cash/Share 38.40
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.89
Net debt/EBITDA N/A
Current ratio 3.62
Quick ratio 3.62